266 Dalbavancin vs Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies

Documenti analoghi

• 675 Outcomes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) by vancomycin dosing regimen and vancomycin trough serum concentrations in the DISCOVER Program
  di: Puttagunta, Sailaja, et al.
  Pubblicazione: (2014)
• 267 Dalbavancin for the treatment of Streptococcal Skin Infections
  di: Puttagunta, Sailaja, et al.
  Pubblicazione: (2014)
• Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies
  di: Dunne, Michael W., et al.
  Pubblicazione: (2015)
• Use of vancomycin as a surrogate for dalbavancin in vitro susceptibility testing: results from the DISCOVER studies
  di: Dunne, Michael W, et al.
  Pubblicazione: (2015)
• Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical Trials
  di: Gonzalez, Pedro L., et al.
  Pubblicazione: (2021)